Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults
This study has been completed.
Study NCT01290601   Information provided by U.S. Army Medical Research and Materiel Command

First Received on February 3, 2011.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
Vivax Malaria
Additional conditions recognized in this trial
Malaria, Vivax
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Tafenoquine
Chloroquine + Primaquine
Additional drug interventions recognized in this trial
Chloroquine
Chloroquine diphosphate
Primaquine
More general drug interventions related to this trial
Amebicides
Analgesics
Analgesics, Non-Narcotic
Anthelmintics
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antimalarials
Antinematodal Agents
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Filaricides
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
U.S. Army Medical Research and Materiel Command
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services